LRRK2 and Dyskinesia: Moreover, a higher levodopa-equivalent dose (LED) and a higher proportion of levodopa-induced complications, including motor fluctuations and dyskinesia, were also observed in PD patients with the LRRK2 G2385R variant in some studies [6, 7].